TY - JOUR T1 - Altered EEG markers of synaptic plasticity in a human model of NMDA receptor deficiency: anti-NMDA receptor encephalitis JF - medRxiv DO - 10.1101/2020.09.28.20203265 SP - 2020.09.28.20203265 AU - Silvano R. Gefferie AU - Angelina Maric AU - Hanne Critelli AU - Sophie Gueden AU - Gerhard Kurlemann AU - Salome Kurth AU - Margherita Nosadini AU - Barbara Plecko AU - Maya Ringli AU - Kevin Rostásy AU - Stefano Sartori AU - Bernhard Schmitt AU - Agnese Suppiej AU - Patrick Van Bogaert AU - Flavia M. Wehrle AU - Reto Huber AU - Bigna K. Bölsterli Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/30/2020.09.28.20203265.abstract N2 - Plasticity of synaptic strength and density is a vital mechanism enabling memory consolidation, learning, and neurodevelopment. It is strongly dependent on the intact function of N-methyl-D-aspartate receptors (NMDAR). The importance of NMDAR is further evident as their dysfunction is involved in many diseases such as schizophrenia, Alzheimer’s disease, neurodevelopmental disorders, and epilepsies. Synaptic plasticity is thought to be reflected by changes of sleep slow wave slopes across the night, namely higher slopes after wakefulness at the beginning of sleep than after a night of sleep. Hence, a functional NMDAR deficiency should theoretically lead to altered overnight changes of slow wave slopes. Here we investigated whether pediatric patients with anti-NMDAR encephalitis, being a very rare but unique human model of NMDAR deficiency due to autoantibodies against receptor subunits, indeed show alterations in this sleep EEG marker for synaptic plasticity.We retrospectively analyzed 12 whole-night EEGs of 9 patients (age 4.3-20.8 years, 7 females) and compared them to a control group of 45 healthy individuals with the same age distribution. Slow wave slopes were calculated for the first and last hour of non-rapid eye movement (NREM) sleep (factor ‘hour’) for patients and controls (factor ‘group’). There was a significant interaction between ‘hour’ and ‘group’ (p = 0.013), with patients showing a smaller overnight decrease of slow wave slopes than controls. Moreover, we found smaller slopes during the first hour in patients (p = 0.022), whereas there was no group difference during the last hour of NREM sleep (p = 0.980). Importantly, the distribution of sleep stages was not different between the groups, and in our main analyses of patients without severe disturbance of sleep architecture, neither was the incidence of slow waves. These possible confounders could therefore not account for the differences in the slow wave slope values, which we also saw in the analysis of the whole sample of EEGs.These results suggest that quantitative EEG analysis of slow wave characteristics may reveal impaired synaptic plasticity in patients with anti-NMDAR encephalitis, a human model of functional NMDAR deficiency. Thus, in the future, the changes of sleep slow wave slopes may contribute to the development of electrophysiological biomarkers of functional NMDAR deficiency and synaptic plasticity in general.HighlightsChanges of slow waves in overnight EEGs are thought to reflect synaptic plasticity.Synaptic plasticity is strongly dependent on intact NMDAR function.Antibody-mediated NMDAR deficiency occurs in patients with anti-NMDAR encephalitis.In this human model of NMDAR deficiency, we found altered slow wave changes.Sleep EEG measures may mark NMDAR-related impairments of synaptic plasticity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by radiz - Rare Disease Initiative Zurich (to S.R.G.), the Swiss National Science Foundation (PCEFP1-181279) (to S.K.), the Swiss National Science Foundation (320030-179443 and 320030-153387) (to R.H.), the Clinical Research Priority Program "Sleep and Health" of the University of Zurich (to R.H.), the Anna Mueller Grocholski foundation and the EMDO foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical committee of the canton of Zurich (BASEC Nr. 2016-02154)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMATLAB scripts used for the analyses in this study are provided by the corresponding author upon reasonable request ER -